[02/15/19]
Posted on February 15, 2019 in Federal Advocacy
Published by: Hall Render
Government Funded After Congress Borders on Another Shutdown Congressional negotiators have reached an agreement on a funding deal that avoids another partial government shutdown that would have occurred at midnight tonight. The measure would fund nine out of fifteen federal departments through September 30, 2019. President Trump is expected to sign the legislation into... READ MORE
Tags: cms, ET3 Model, government shutdown, health it, Medicare, Medicare Buy-In, This Week in Washington
[02/15/19]
Posted on February 15, 2019 in Health Law News
Published by: Hall Render
Beginning April 1, 2019, Medicare Part C and D plans, PACE organizations and 1876 cost contract plans (“Plans”) will be required to deny payment for services rendered or prescriptions ordered by any provider on the new Centers for Medicare & Medicaid Services (“CMS”) Preclusion List. The Preclusion List, which was first made available to... READ MORE
Tags: cms, Listed Providers, Medicare Part C, Medicare Part D, National Provider Plan and Enumeration System, NPPES, pecos, pharmacy, pharmacy benefit managers, Preclusion List
[02/01/19]
Posted on February 1, 2019 in Federal Advocacy
Published by: Hall Render
HHS Previews 2019 Regulatory Agenda At a symposium on Tuesday, Deputy HHS Secretary Eric Hargan and CMS Administrator Seema Verma outlined the administration’s health care strategy for 2019, which includes advancing the use of technology, adjusting payments in rural areas and testing new ways to reward high-quality care and reforms to the Stark and... READ MORE
Tags: cms, Drug Pricing, Drug Rebate, Government Funding, Medicare Part D Rebate Program, Rural Health, This Week in Washington, Value-Based Care
[01/18/19]
Posted on January 18, 2019 in Health Law News
Published by: Hall Render
January 1, 2019 marked the start of a new data collection period for laboratories pursuant to the Medicare Clinical Diagnostic Laboratory Tests Payment System Final Rule (“CLFS Rule”).¹ The CLFS Rule establishes the Centers for Medicare & Medicaid Services’s (“CMS’s”) new private payor-based rate-setting system for clinical diagnostic laboratory tests (“CDLTs”) paid under the... READ MORE
Tags: Centers for Medicare & Medicaid Services, CLFS, clinical laboratories, clinical laboratory, clinical laboratory fee schedule, cms, hospital outreach laboratory, Medicare Clinical Diagnostic Laboratory Tests Payment System Final Rule, Medicare Part B, PAMA, Protecting Access to Medicare Act of 2014
[01/11/19]
Posted on January 11, 2019 in Health Law News
Published by: Hall Render
On December 27, 2018, a federal judge ruled in favor of hospital associations and hospitals challenging the reduction in reimbursement for drugs purchased at a discount under the 340B Program established in the 2018 Outpatient Prospective Payment System final rule (“2018 OPPS Rule”). Judge Rudolph Contreras of the United States District Court in Washington,... READ MORE
Tags: 340B, 340B Payment Cuts, 340B Program, cms, hhs, OPPS, Outpatient Prospective Payment System
[12/31/18]
Posted on December 31, 2018 in Long-Term Care, Home Health & Hospice
Published by: Hall Render
On November 30, 2018, CMS issued a Memorandum to State Survey Agency Directors (QSO-19-02-NH), announcing its concerns about adequate registered nurse staffing in skilled nursing facilities and that it will provide CMS Regional Offices and State Survey Agencies with a list of facilities with potential staffing issues to support survey activities for evaluating sufficient staffing and... READ MORE
Tags: acute care, CIVIL MONEY PENALTIES, CIVIL MONEY PENALTY, cmp, cms, FACILITY ASSESSMENT, long term care, nursing home, PAYROLL BASED JOURNAL, PBJ, POST ACUTE CARE, REGISTERED NURSE; COMPLIANCE, SKILLED NURSING, staffing, survey
[12/13/18]
Posted on December 13, 2018 in Health Law News, Long-Term Care, Home Health & Hospice
Published by: Hall Render
Last week, the United States Court of Appeals for the Seventh Circuit (“Court of Appeals”) released an opinion that confirmed a Centers for Medicare & Medicaid Services (“CMS”) assessment of an immediate jeopardy citation and an $83,800 civil money penalty against a nursing home for inadequately addressing sexual interactions between cognitively impaired nursing home... READ MORE
Tags: acute care, CIVIL MONEY PENALTIES, CIVIL MONEY PENALTY, cmp, cms, compliance, COMPLIANCE PROGRAM, home, long term care, NURSIN, POLICIES, policy, POST ACUTE CARE, SKILLED NURSING, survey
[11/29/18]
Posted on November 29, 2018 in Long-Term Care, Home Health & Hospice
Published by: Hall Render
This is another article in a series discussing the complete overhaul of Part 483 to Title 42 of the Code of Federal Regulations the Requirements for States and Long-Term Care Facilities (“Final Regulations”) by the Centers for Medicare & Medicaid Services (“CMS”). To view other articles in this series, click here. Beginning on November 28,... READ MORE
Tags: acute care, cms, compliance, COMPLIANCE AND ETHICS PROGRAM, COMPLIANCE PROGRAM, ETHICS PROGRAM, long term care, nursing home, PHASE 3, POST ACUTE CARE, SKILLED NURSING, Skilled Nursing Compliance and Ethics Program, survey
[11/21/18]
Posted on November 21, 2018 in Health Law News
Published by: Hall Render
The Centers for Medicare & Medicaid Services (“CMS”) recently issued a proposed rule (“Proposed Rule”) that would require pharmaceutical manufacturers to disclose the list price for a typical course of treatment of prescription drugs and biologics covered by Medicare or Medicaid in direct-to-consumer television advertisements. This policy development comes just two months after the... READ MORE
Tags: Centers for Medicare & Medicaid Services, cms, Drug Prices, PBM, prescription drugs, Wholesale Acquisition Cost
[11/09/18]
Posted on November 9, 2018 in Health Law News
Published by: Hall Render
The Centers for Medicare & Medicaid Services (“CMS”) Center for Medicare and Medicaid Innovation proposed to lower the cost of Medicare Part B outpatient prescription drugs by establishing their prices based on lower drug prices of other advanced industrial nations as compiled in an “international price index” (“IPI”) and changing the way the current drug... READ MORE
Tags: Advance Notice of Proposed Rulemaking with Comment, cms, Drug Costs, Drug Prices, Drug Pricing, Drugs and Biologics, international price index, IPI, IPI Model, Medicare Part B, Model Vendors, PhRMA, Target Price